Related Experiment Videos

Extracorporeal shock wave lithotripsy for renal stones in children

D Picramenos1, C Deliveliotis, K Alexopoulou

  • 1Department of Urology, Sismanoglion Hospital, Athens, Greece.

Urologia Internationalis
|January 1, 1996
PubMed

Insights

Extracorporeal shock wave lithotripsy (ESWL) effectively treats pediatric nephrolithiasis, achieving an 82% stone-free rate with minimal complications. This low-risk procedure is recommended as the primary treatment for children

Area of Science:

  • Pediatric Urology
  • Nephrology
  • Surgical Technology

Background:

  • Nephrolithiasis, or kidney stones, affects children, necessitating safe and effective treatment options.
  • Extracorporeal shock wave lithotripsy (ESWL) is a non-invasive modality for stone removal.

Purpose of the Study:

  • To evaluate the efficacy and safety of ESWL for treating kidney stones in pediatric patients.
  • To determine the long-term stone clearance and complication rates following ESWL in children.

Main Methods:

  • A cohort of 50 children (8 months to 14 years) with renal calculi underwent ESWL between 1986 and 1994.
  • Treatments utilized Dornier HM3 and HM4 lithotripters under anesthesia, with 400-2000 shock waves at 18 kV.
  • Follow-up included clinical assessment and DMSA scans to evaluate renal function and stone clearance.

Main Results:

  • An overall stone clearance rate of 66% was observed at 1 month, reaching 82% stone-free after a mean follow-up of 33 months.
  • Complications included 10 urinary tract infections and 5 cases of Steinstrasse; no permanent renal function impairment was detected.
  • Children demonstrated high stone fragmentation and clearance rates, comparable to or exceeding adult outcomes.

Conclusions:

  • ESWL is a safe and effective primary treatment for pediatric nephrolithiasis, including complex and staghorn calculi.
  • The procedure offers a low-risk profile with high success rates, making it the treatment of choice for childhood kidney stones.
  • ESWL's efficacy in children supports its use as an initial monotherapy approach for urinary tract lithiasis.

Related Concept Videos